Terms ending in 2030
Every in-force patent on Acceleron Pharma Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,138,142 | Methods for Increasing Adiponectin in a Patient in Need Thereof In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 8,945,877 | Polynucleotides Encoding BMP-ALK3 Antagonists In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 8,178,488 | Methods for Increasing Thermogenic Adipocytes In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 8,293,881 | An Isolated Nucleic Acid Encoding a Truncated Actriib Fusion Protein In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 8,703,694 | Methods for Increasing Thermogenic Adipocytes In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 9,745,559 | A Method for Decreasing the Body Fat Content in a Subject by Administering an Actriib Protein In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 9,790,284 | Methods for Increasing Thermogenic Adipocytes In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 10,358,633 | Method for Decreasing the Body Fat Content in a Subject by Administering an Actriib Protein In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | |
| US 10,968,282 | Methods for Screening Compounds for Increasing Thermogenic Adipocytes In force · High confidence | Acceleron Pharma Inc. | In force | High confidence | |
| US 11,066,654 | Methods and Compositions for Reducing Serum Lipids In force · Medium confidence | Acceleron Pharma Inc. | In force | Medium confidence | |
| 3 more term ends in 2030 · Pro | |||||
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.